Saving changes...

Done

Error

Osteonecrosis of the jaw: Risk management of patients who have received osteoporosis therapy

Osteonecrosis of the jaw: Risk management of patients who have received osteoporosis therapy

Osteonecrosis of the jaw: Risk management of patients who have received osteoporosis therapy

H. Edward Lyon, DDS
H. Edward Lyon, DDS
on behalf of DrBicuspid

$50.00 $ 50.00 $ 50.00

$50.00 $ 50.00 $ 50.00

$ 50.00 $ 50.00 $ 50.00
$ 50.00 $ 50.00 $ 50.00
Normal Price: $50.00 $50.00

Review:

Launch date: 23 Feb 2017
Expiry Date:

Last updated: 07 Mar 2017

Reference: 168455

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

The title calls attention to a current subject in dentistry – the adverse event of osteonecrosis of the jaw that results from the popular medication oral bisphosphonate used in the treatment and prevention of osteoporosis.

Objectives

Objectives
Upon completion of this course, the participant should be able to do the following:Be aware that millions of people, especially postmenopausal women, are taking oral bisphosphonate drugs for the treatment or prevention of osteoporosis, and this drug has a risk of causing osteonecrosis of the jaw after certain dental procedures.Be aware of the clinical manifestations of osteonecrosis of the jaw.Understand the indications for both oral and intravenous bisphosphonatesBe aware of the recommendations of various professional dental organizations (including the American Dental Association) to reduce the risk of osteonecrosis of the jaw.Recognize which bisphosphonates are a risk for causing osteonecrosis of the jaw.Discuss with patients who are taking an oral bisphosphonate for osteoporosis what the potential risk for osteonecrosis of the jaw is after various dental procedures.Understand the need for the patient’s optimal oral health and the importance of conveying this to patients.
H. Edward Lyon, DDS

Author Information Play Video Bio

H. Edward Lyon, DDS
on behalf of DrBicuspid

H. Edward Lyon, DDS, served as a member of the Oral Health Practice Facility at the University of Kentucky College of Dentistry after a career as a commissioned officer in the Division of Hospitals of the U. S. Public Health Service. He is a graduate of Indiana University School of Dentistry and completed an advanced general practice residency at the USPHS Hospital, Staten Island, NY. Most of his professional career has been directing or serving as attending faculty in general practice residency programs. He has been active in research and publication and has lectured extensively in the United States and Europe. Dr. Lyon has provided abstracts of current dental literature to foreign journals and other publications for over 20 years.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • American Dental Association Continuing Education Recognition Program ( ADA CERP)
  • 2.00 Credits

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error